In addition to HAT1 mutations, HAT1 overexpression is also frequent in multiple cancer types, including colon cancer [35], esophageal cancer [36], and lymphoma [37], exacerbating tumor malignancy. This evidence concerns the gene HAT1 and lymphoma.